UPDATE: Morgan Stanley Reiterates On CVS Caremark Ahead Of CFO Conference Call

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on

, but removed the $80.00 price target. In the report, Morgan Stanley noted, “We are hosting CVS's CFO Dave Denton on Thursday 5/29 at 1pm as part of our CEO/CFO conference call series. On the call we will discuss key investor debates, highlighted below.” CVS Caremark closed on Tuesday at $77.17.